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ABSTRACT  1 
Background and aims: There is little evidence on post hoc- derived dietary patterns (DP) 2 
and all-cause mortality in Southern-European populations. Furthermore, the potential effect 3 
modification of a DP by a nutritional intervention has not been sufficiently assessed. We 4 
assessed the association between a posteriori defined baseline major DP and total mortality or 5 
cardiovascular events within each of the three arms of a large primary prevention trial 6 
(PREDIMED) where participants were randomized to two active interventions with 7 
Mediterranean-type diets or to a control group (allocated to a low-fat diet). 8 
Design: We followed-up 7216 participants for a median of 4.3 years. A validated 137-item 9 
food-frequency questionnaire was administered. Baseline DP were ascertained through factor 10 
analysis based on 34 predefined groups. Cox regression models were used to estimate 11 
multivariable-adjusted hazard ratios (HR) for cardiovascular disease (CVD) or mortality 12 
across quartiles of DP within each of the three arms of the trial.  13 
Results: We identified two major baseline DP: the first DP was rich in red and processed 14 
meats, alcohol, refined grains and whole dairy products and was labeled Western Dietary 15 
Pattern (WDP). The second DP corresponded to a “Mediterranean-type” dietary pattern 16 
(MDP). During follow-up, 328 participants died. After controlling for potential confounders, 17 
higher baseline adherence to the MDP was associated with lower risk of CVD (adjusted HR 18 
for fourth vs. first quartile: 0.52; 95% CI (Confidence Interval): 0.36, 0.74; p-trend <0.001) 19 
and all-cause mortality (adjusted HR: 0.53; 95% CI: 0.38, 0.75; p-trend <0.001), regardless of 20 
the allocated arm of the trial. An increasing mortality rate was found across increasing 21 
quartiles of the WDP in the control group (allocated to a low-fat diet), though the linear trend 22 
was not statistically significant (p=0.098).   23 
CONCLUSIONS: Higher adherence to an empirically-derived MDP at baseline was 24 
associated with a reduced risk of CVD and mortality in the PREDIMED trial regardless of the 25 
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allocated arm. The WDP was not associated with higher risk of mortality or cardiovascular 26 
events.  27 
INTRODUCTION 28 
The main causes of death in developed countries are cancer and cardiovascular disease (CVD)*, 29 
chronic conditions in which prevention by lifestyle, particularly a healthy diet, plays an 30 
important role.  31 
In the context of overall dietary patterns (DP), many epidemiological studies have examined the 32 
health benefits of an a priori defined Mediterranean diet (MeDiet) and found consistent evidence 33 
that individuals who better adhere to this DP have a healthier ageing and a longer life span  [1, 34 
2]. 35 
In the last decade there has been growing interest in assessing the relationships between diet and 36 
disease through the study of whole DP instead of focusing on single nutrients or foods [3]. The 37 
approach consisting in collecting food data and using them afterwards to identify the DP actually 38 
followed by the study subjects is known as the a posteriori approach (post hoc). It detects DP 39 
empirically derived from available data using principal component analysis or factor analysis [4-40 
6]. Though several studies have assessed the relationship between a posteriori DP and various 41 
health outcomes [7], including all-cause mortality [7-10], there is little evidence on post hoc DP 42 
and mortality in Southern European populations [11]. An interesting issue that has not been 43 
explored is whether the adverse effects of a DP can be modified by a nutritional intervention. 44 
We evaluated the association between a posteriori defined major DP and CVD incidence or 45 
total mortality in each of the three arms of a large randomized trial testing an intervention 46 
with a Mediterranean-type diets for the primary prevention of CVD (the PREDIMED study). 47 
Participants in the PREDIMED trial were randomized to two active interventions with 48 
Mediterranean-type diets or to a control group (allocated to a low-fat diet). We assessed 49 
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whether this intervention was able to modify the association between baseline DP and two 50 
outcomes: all-cause mortality and the risk of cardiovascular events.   51 
METHODS 52 
Subjects 53 
The PREDIMED (PREvención con DIeta MEDiterránea) trial (ISRCTN35739639) is a 54 
multicenter, randomized, controlled, parallel group, primary prevention trial conducted in 55 
Spain to assess the effects of MeDiet on major cardiovascular events. The study protocol has 56 
been published elsewhere [12, 13] and full details are available at www.predimed.es. Between 57 
October 2003 and June 2009 we recruited 7,447 high-risk participants and randomly assigned 58 
them to one of three dietary interventions: two MeDiets supplemented with either extra virgin 59 
olive oil (EVOO) or mixed nuts and a control group (low-fat diet). Participants in the two 60 
MeDiet groups received either extra-virgin olive oil (to consume 50 g/d) or mixed nuts per 61 
day (15 g/d walnuts, 7.5 g/d hazelnuts, and 7.5 g/d almonds) at no cost. They received 62 
instructions directed to upscale the traditional MeDiet 14-item score, including 1) the use of 63 
olive oil for cooking and dressing; 2) increased consumption of vegetables, nuts, and fish 64 
products; 3) consumption of white meat instead of red or processed meat; 4) preparation of 65 
home-made sauce by simmering tomato, garlic, onion and aromatic herbs with olive oil to 66 
dress vegetables, pasta, rice and other dishes; and 5) for alcohol drinkers, to follow a 67 
moderate pattern of red wine consumption. Participants allocated to the control group 68 
received small nonfood gifts and were advised to reduce all types of fat and were given 69 
written recommendations according to American Heart Association guidelines. No total 70 
calorie restriction was advised, nor was physical activity promoted in any of the three groups.  71 
The primary endpoint for the main trial was a composite of cardiovascular events. Total 72 
mortality was also used as a secondary outcome. All participants provided written informed 73 
consent to a protocol approved by the institutional review boards of the recruiting centers.  74 
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Eligible participants were community-dwelling men aged 55-80 years and women aged 60-80 75 
years without previous CVD who fulfilled at least one of the following criteria: type-2 76 
diabetes or 3 or more cardiovascular risk factors, namely smoking, hypertension, 77 
dyslipidemia, overweight (BMI ≥ 25 kg/m2) or a family history of premature CVD. For the 78 
present study we excluded 231 participants, 79 of them because their baseline food-frequency 79 
questionnaires (FFQ) were missing and 152 who displayed out-of-range total energy intake 80 
(<500 or >3500 kcal/d in women or <800 or >4000 kcal/d in men) [14]. Consequently, the 81 
final sample size included 7,216 participants.  82 
Dietary assessment 83 
Data on dietary intake were collected at baseline with a semi-quantitative 137-item validated 84 
FFQ [15]. For each item, a typical portion size was included, and consumption frequencies 85 
were registered in 9 categories that ranged from “never or almost never” to “≥ 6 times/day”. 86 
Daily food consumption was estimated by multiplying the portion size of each food item by 87 
its consumption frequency. Energy and nutrient intake were derived using a computer 88 
program based on available information in Spanish food composition tables. 89 
Assessment of non- dietary variables 90 
Several questionnaires were used at baseline examination to collect sociodemographic data, 91 
lifestyle variables, history of illnesses, and medication use. A validated questionnaire [16] 92 
was used to collect information on physical activity.  93 
Ascertainment of mortality 94 
During follow-up dietitians delivered the nutritional intervention with quarterly individual 95 
visits and quarterly group sessions [13]. The questionnaires and examinations carried out at 96 
baseline were repeatedly administered every year to all participants. Besides, once a year a 97 
team of medical doctors reviewed medical records to collect information on the main 98 
outcomes, both in primary care centers and hospitals. Also, yearly inquiries were made of the 99 
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National Death Index. Considering all the sources of information, we are reasonably confident 100 
that ascertainment of mortality outcomes was complete. When a death was identified using 101 
any of these primary sources, medical records were requested where the patient had been 102 
cared for and submitted to the end-point adjudication committee for assignment of the cause 103 
of death. This committee was blinded with respect to the intervention group and the food 104 
habits of participants.   105 
Statistical analyses 106 
The 137 food items included in the FFQ were grouped into 34 predefined food categories. A 107 
principal component analysis was applied to these 34 categories in order to identify a reduced 108 
number of factors that could explain the maximum proportion of the variance from the 109 
original groups. Food groups with absolute loading >0.29 were considered relevant 110 
components of the identified patterns (Table 1).  111 
The score for each participant was calculated by summing up the consumption of each food 112 
group weighted by each factor score obtained in the factor analysis. The resulting quantitative 113 
scores were categorized into quartiles. The Scree plot and the criteria of eigenvalues >2 were 114 
used to select factors. We selected 2 factors that accounted for 13% of the total variance. 115 
Baseline characteristics and nutritional habits of participants according to their quartiles of 116 
adherence to both selected factors (dietary patterns) were analyzed (tables 2 and 3) and p 117 
values for linear trend tests were calculated for each variable. Nutritional variables were log-118 
transformed to calculate the p values for linear trend. 119 
We used Cox regression models with length of follow-up since randomization for the trial as 120 
the primary time variable. The exposure time was calculated as the time elapsed between 121 
recruitment and the date of death for deceased participants, the last study visit, or the last 122 
recorded clinical event of participants still alive. Hazard ratios (HR) with 95% confidence 123 
intervals (CI) for the three upper quartiles compared to the lowest quartile of each DP were 124 
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calculated. In multivariable model 1, potential confounders included as covariates were sex, 125 
age (continuous), intervention group and recruitment center. We constructed a second model 126 
(multivariable model 2) that also included as covariates smoking status (never, former or 127 
current smoker), baseline BMI (kg/m2, continuous), physical activity during leisure time 128 
(METs min/day, continuous), baseline self-reported hypertension, hypercholesterolemia, 129 
diabetes, history of previous depression and educational level (three categories). We 130 
conducted analyses stratified by each of the three arms of the trial. We repeated the main 131 
analyses adjusting also for total energy intake (kcal/day, continuous). Tests of linear trend 132 
across successive quartiles of adherence to each of the two food patterns were calculated. 133 
In order to assess the effects of the intervention across the quartiles of baseline adherence to 134 
each DP, a new variable was created combining the joint exposure to the quartile of adherence 135 
to the studied DP and the intervention. This cross-classification was conducted with the aim 136 
of assessing whether the intervention was able to modify the association between baseline 137 
adherence to DP and the risk of death or cardiovascular events. We used inverse probability 138 
weighting (IPW) not only to control for baseline confounding but also to estimate the absolute 139 
risks according to the joint classification of participants in 12 groups by both quartile of the 140 
dietary pattern and intervention arm allocated in the trial [17]. To calculate the weights we 141 
used as predictors baseline values of age, sex, smoking habit, BMI, physical activity, 142 
hypertension, hypercholesterolemia, diabetes, educational level and history of depression. 143 
This method allows analyzing observational studies (the effects of baseline adherence to DP 144 
in our case) in a way similar to a randomized trial, under the assumption that all relevant 145 
confounders are included in the computation of weights. We estimated the absolute risks of 146 
mortality (or cardiovascular events) for each combined category of the DP (quartiles) and the 147 
intervention group (3 categories), using the weighted pseudo-population obtained with the 148 
IPW procedure. Relative risks were also calculated for upper quartiles of each DP using as 149 
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reference the first quartile of the DP, within each intervention group and the p for linear trend 150 
was calculated. 151 
 We used STATA version 12.0 (StataCorp) for all analyses. 152 
RESULTS  153 
The mean (± SD) age of the 7,216 participants was 67.0 (6.2) y. Participants were followed-154 
up for an average of 4.3 y. During this period 328 deaths were recorded; the mean age at 155 
death was 73.8 (6.9).  156 
Factor analysis revealed two major DP. Absolute factor loadings >0.29 for each DP are 157 
presented in Table 1. The first factor was characterized by a high consumption of high fat 158 
processed meats and red meats, alcohol, refined grains, canned fish, whole-fat dairy products, 159 
sauces, eggs, processed meals, commercial bakery and chocolates, whereas consumption of 160 
low-fat dairy products was inversely loaded. We labeled it as “Western Dietary Pattern 161 
(WDP)”. 162 
The second factor was loaded with vegetables, EVOO, walnuts, oily fish and canned fish, 163 
fruits, other nuts, whole-wheat bread, white fish and low fat dairy products. In addition, it was 164 
defined by a low consumption (negative loadings) of refined grains and of other olive oils 165 
different from EVOO. We labeled this second factor as Mediterranean-type dietary pattern 166 
(MDP). 167 
The baseline characteristics of participants by quartiles of the WDP and the MDP are shown 168 
in Tables 2 and 3 respectively. Subjects with a higher adherence to the WDP were more 169 
likely to be men, current smokers and were more physically active. They also showed higher 170 
total energy intake and significantly higher intakes of fat, except for monounsaturated fatty 171 
acids, and also greater consumption of most food groups with the exception of vegetables and172 
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 Western Dietary Pattern Mediterranean dietary 
pattern 
High fat processed meat 0.55  
Alcohol 0.45  
Red meat 0.45  
Refined grains 0.40 -0.30 
Canned fish/Seafood 0.38 0.38 
Sauces 0.33  
Processed meal 0.32  
Whole dairy products 0.31  
Eggs 0.30  
Commercial bakery 0.29  
Chocolates 0.29  
Low fat dairy products -0.33 0.29 
Olive oil (not extra-virgin)   -0.39 
White fish  0.33 
Whole grain bread   0.35 
Nuts (not walnut)  0.36 
Fruit  0.36 
Oily fish  0.39 
Walnuts  0.40 
Extra-virgin olive oil  0.47 
Vegetables  0.51 
Table 1. Factor loadings for the two major dietary patterns in the PREDIMED study 
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 WDP1 
(n=1804) 
WDP2 
(n=1804) 
WDP3 
(n=1804) 
WDP4 
(n=1804) 
p for trend 
Men (%) 23.0 33.0 47.5 67.0 <0.001 
Smoking status      
   Former smokers (%) 16.4 20.4 27.0 34.5 <0.001 
   Current smokers (%) 7.1 10.7 15.0 22.7 <0.001 
Diabetes (%) 55.7 49.0 45.2 44.5 <0.001 
Hypertension (%) 84.0 84.1 82.9 79.9 <0.001 
Age (y) 68.2±6.0 67.4±6.1 66.7±6.1 65.8±6.3 <0.001 
Weight (kg) 74.3±11.2 75.4±12.0 77.4±12.0 80.0±11.8 0.006 
BMI (kg/m2) 30.2±4.0 29.9±3.9 29.9±3.8 29.8±3.6 <0.001 
Physical activity during leisure time (METs-min/day) 210.2±223.5 210.4±205.6 242.9±253.7 260.8±264.2 <0.001 
Total energy intake (kcal/d) 1839.3±444.5 2053.8±394.2 2294.2±389.2 2757.4±462.4 <0.001 
Carbohydrate intake (% total energy) 43.1±7.2 42.4±7.0 41.3±6.9 40.3±7.0 <0.001 
Protein intake (% total energy) 17.8±3.1 16.9±2.6 16.3±2.5 15.4±2.4 <0.001 
Fat intake (% total energy) 38.3±7.5 39.0±6.7 39.7±6.5 39.8±6.3 <0.001 
Monounsaturated fatty acid intake (% total energy) 19.5±5.2 19.5±4.6 19.6±4.3 19.4±4.0 0.339 
Polyunsaturated fatty acid intake (% total energy) 5.9±2.1 6.2±2.0 6.4±2.1 6.4±2.0 <0.001 
Saturated fatty acid intake (% total energy) 9.3±2.1 9.7±2.1 10.2±2.1 10.7±2.3 <0.001 
Alcohol intake (g/d) 2.2±5.2 4.6±7.7 8.8±11.9 17.7±20.6 <0.001 
Vegetables (g/d) 336.3±157.3 335.0±145.1 329.1±142.5 335.8±143.3 0.927 
Fruits (g/d) 365.0±202.9 369.7±200.9 371.1±199.4 367.7±202.7 0.355 
Whole-fat dairy products (g/d) 42.3±76.6 78.0±126.4 110.8±152.5 163.8±192.2 <0.001 
Low-fat dairy products (g/d) 390.5±239.6 300.0±221.0 243.8±206.5 189.9±202.1 <0.001 
Table 2. Baseline characteristics of the 7216 participants according to quartiles of adherence to Western Dietary Pattern (WDP) 
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Eggs (g/d) 15.9±9.9 18.8±9.8 21.1±9.7 24.3±12.9 <0.001 
Red meat (g/d) 30.8±24.4 43.3±28.9 55.2±33.3 72.2±45.2 <0.001 
White fish (g/d) 46.4±33.3 44.6±28.9 43.1±26.4 42.0±31.0 <0.001 
Oily fish (g/d) 22.3±21.5 24.5±20.9 24.8±20.2 27.0±22.0 <0.001 
Other fish and seafood (g/d) 18.4±16.1 25.8±18.9 31.3±21.7 41.1±30.7 <0.001 
High-fat processed meat (g/d) 1.8±3.4 4.5±5.9 7.5±8.7 16.2±16.8 <0.001 
Processed meals (g/d) 0.5±1.2 0.9±1.8 1.9±2.3 2.5±4.1 <0.001 
Refined grains (g/day) 62.7±60.4 104.0±76.1 126.4±86.3 160.5±103.7 <0.001 
Whole bread (g/d) 55.3±77.2 24.5±52.9 18.7±46.2 12.5±38.6 <0.001 
Chocolates (g/d) 2.1±4.6 3.9±7.6 5.3±8.1 9.4±15.1 <0.001 
Commercial bakery (g/d) 3.1±7.1 5.9±10.5 9.0±14.6 14.1±20.9 <0.001 
Sauces (g/d) 0.9±1.5 1.4±2.0 2.0±2.7 3.2±3.9 <0.001 
Extra-virgin olive oil (g/d) 16.8±21.1 19.7±22.6 22.2±23.4 25.7±24.5 <0.001 
Other olive oils (g/d) 19.7±20.3 17.9±19.1 17.7±20.3 16.5±20.6 0.224 
Nuts (g/d) 7.1±11.3 5.4±8.3 11.1±14.2 13.3±16.1 <0.001 
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 MDP1 
(n=1804) 
MDP2 
(n=1804) 
MDP3 
(n=1804) 
MDP4 
(n=1804) 
p for trend 
Men (%) 46.0 42.0 41.0 40.5 <0.001 
Smoking status      
   Former smokers (%) 22.8 24.5 24.8 26.3 0.242 
   Current smokers (%) 17.0 15.5 11.6 11.5 <0.001 
Diabetes (%) 50.0 47.1 48.8 48.7 0.728 
Hypertension (%) 83.1 83.4 81.3 83.0 0.540 
Age (y) 67.6±6.4 67.4±6.1 66.9±6.0 66.3±6.2 <0.001 
Weight (kg) 76.8±12.1 76.8±12.1 76.3±11.7 76.5±12.2 0.007 
BMI (kg/m2) 30.2±3.7 30.0±3.8 29.9±3.9 29.8±4.0 0.001 
Physical activity during leisure time (METs-min/week) 211.2±219.4 224.7±247.9 235.0±225.2 253.2±258.9 <0.001 
Total energy intake (kcal/d) 2156.1±575.9 2122.2±5239 2189.7±487.5 2476.6±510.9 <0.001 
Carbohydrate intake (% total energy) 43.2±7.5 42.2±7.0 41.2±6.7 40.5±6.9 <0.001 
Protein intake (% total energy) 15.4±2.6 16.6±2.7 17.1±2.8 17.3±2.8 <0.001 
Fat intake (% total energy) 38.7±7.1 38.6±6.6 39.4±6.6 40.2±6.7 <0.001 
Monounsaturated fatty acid intake (% total energy) 19.3±4.8 19.2±4.4 19.6±4.5 19.9±4.5 <0.001 
Polyunsaturated fatty acid intake (% total energy) 5.9±2.2 5.9±1.8 6.2±1.9 6.8±2.1 <0.001 
Saturated fatty acid intake (% total energy) 10.3±2.4 10.0±2.2 9.9±2.1 9.6±2.1 <0.001 
Alcohol intake (g/d) 9.2±16.1 8.3±13.7 8.1±13.8 7.7±12.4 0.001 
Vegetables (g/d) 254.1±101.2 300.4±107.9 345.5±121.2 436.6±178.9 <0.001 
Fruits (g/d) 285.2±156.5 340.0±171.1 385.8±197.8 462.6±229.3 <0.001 
Whole-fat dairy products (g/d) 159.9±199.6 94.4±141.6 72.5±112.1 68.2±110.2 <0.001 
Low-fat dairy products (g/d) 186.9±196.0 270.6±215.5 312.1±231.2 354.5±241.1 <0.001 
Table 3. Baseline characteristics of the 7216 participants according to quartiles of adherence to Mediterranean Dietary Pattern (MDP) 
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Eggs (g/d) 19.6±11.7 19.5±10.8 19.8±10.1 21.1±11.6 <0.001 
Red meat (g/d) 53.2±40.3 50.5±34.6 49.2±35.7 48.6±36.7 <0.001 
White fish (g/d) 33.0±24.7 41.0±25.8 46.0±26.3 56.1±37.0 <0.001 
Oily fish (g/d) 16.1±14.1 21.5±18.0 25.9±20.3 35.1±26.0 <0.001 
Other fish and seafood (g/d) 19.2±16.5 25.4±19.6 30.4±21.9 41.6±30.0 <0.001 
High-fat processed meat (g/d) 8.4±13.3 8.0±11.1 7.0±10.3 6.7±10.7 <0.001 
Processed meals (g/d) 1.6±3.4 1.3±2.6 1.1±2.3 1.1±2.2 0.010 
Refined grains (g/day) 153.2±102.4 121.1±89.4 97.2±75.7 82.2±74.6 <0.001 
Whole bread (g/d) 6.3±22.7 17.4±41.6 29.9±55.2 57.2±82.1 <0.001 
Chocolates (g/d) 4.3±8.3 4.2±7.8 5.0±10.2 7.2±12.8 <0.001 
Commercial bakery (g/d) 10.0±18.7 7.7±14.1 7.5±13.6 6.9±12.0 <0.001 
Sauces (g/d) 1.9±2.55 1.9±2.7 1.8±2.8 1.9±3.2 0.213 
Extra-virgin olive oil (g/d) 6.5±13.6 16.3±20.2 25.3±22.7 36.3±23.6 <0.001 
Other olive oils (g/d) 30.0±20.5 20.0±19.4 13.6±18.2 8.2±15.1 <0.001 
Nuts (g/d) 4.1±6.3 7.1±8.9 10.3±11.7 18.9±19.1 <0.001 
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fruit. They had a statistically significant lower consumption of white fish, whole bread, and 173 
low-fat dairy products. Participants with a higher score for the MDP were more likely to be 174 
women, non-smokers and more physically active. They presented a reduced intake of 175 
carbohydrate, and higher intake of protein and fat, specifically mono- and poly-unsaturated 176 
fat.  177 
Table 4 shows the hazard ratios (HR) for all-cause mortality according to baseline adherence 178 
to both DP in the whole PREDIMED cohort. After adjustment for sex, age, intervention group 179 
and recruitment center (model 1), there was no significant association between the upper 180 
quartile of WDP and death (HR 1.07; 95% CI: 0.77,1.50). Model 2, including additional 181 
confounders, showed similar results (HR 1.04; 95% CI: 0.74,1.47). 182 
However, adherence to the empirically-derived MDP did show an inverse association that was 183 
statistically significant for the linear trend (p<0.001) and suggested strong risk reductions in 184 
the two upper quartiles, with HR 0.74 (95% CI: 0.54,0.99) for the third versus the first 185 
quartile and HR 0.53 (95% CI: 0.38, 0.75) for the fourth versus the first quartile (all in model 186 
2).  187 
When we assessed the association between empirically derived DP and cardiovascular events 188 
(myocardial infarction, stroke or cardiovascular death, i.e. the primary end-point of the main 189 
trial) no significant association was found between the WDP and the risk of cardiovascular 190 
events (HR for the upper versus the lowest quartile: 1.00; 95% CI: 0.70,1.43; adjusted for sex, 191 
age, intervention group and recruitment center) (table 5). Model 2, including additional 192 
confounders, showed similar results (HR 1.05; 95% CI: 0.73,1.51).  193 
In contrast, a decreased risk of cardiovascular events was observed among subjects classified 194 
in the third and fourth baseline quartiles of the empirically-derived MDP (HR 0.60; 95% CI: 195 
0.42, 0.81 and HR 0.52; 95%CI: 0.36, 0.74; respectively in model 1 and 2). Results were 196 
similar 197 
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1Adjusted for sex, age, recruitment center and interventional group. 
2Adjusted for sex, age, recruitment center and interventional group, smoking status (never smoker, former smoker and current smoker), baseline body mass 
index, physical activity during leisure time, self-reported hypertension, self-reported depression, self-reported diabetes, self-reported hypercholesterolemia and 
education level (three categories) 
*p<0.05 ** p<0.001 
 
Western dietary pattern Q1 Q2 Q3 Q4  
n= 1804 n= 1804 n= 1804 n=1804  p for trend 
Overall mortality (n) 71 69 86 102  
Person-years 7635 7605 7805 8034  
Men (%) 23.0 33.0 47.5 67.0 <0.001 
Age (y) 68.2±6.0 67.4±6.1 66.7±6.1 65.8±6.3 <0.001 
Multivariable model1 1(ref) 0.94 (0.67-1.32) 1.09 (0.78-1.51) 1.07 (0.77-1.50) 0.53 
Multivariable model2 1(ref) 0.93 (0.66-1.30) 1.05 (0.75-1.46) 1.04 (0.74-1.47) 0.65 
Mediterranean dietary  Q1 Q2 Q3 Q4  
Pattern n= 1804 n= 1804 n= 1804 n= 1804 p for trend 
Overall mortality (n) 115 85 73 55  
Person-years 7882 7613 7619 7963  
Men (%) 46.0 42.0 41.0 40.5 <0.001 
Age (y) 67.6±6.4 67.4±6.1 66.9±6.0 66.3±6.2 <0.001 
Multivariable model1 1(ref) 0.80 (0.60-1.06) 0.70 (0.52-0.95)** 0.51 (0.36-0.71)** <0.001 
Multivariable model2 1(ref) 0.82 (0.62-1.10) 0.74 (0.54-0.99)** 0.53 (0.38-0.75)** <0.001 
Table 4. Hazard ratios for total mortality according to quartiles of baseline adherence to the Western dietary pattern and  
Mediterranean dietary pattern in the PREDIMED study with the three intervention groups considered together (n= 7216)
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1Adjusted for sex, age, recruitment center and interventional group. 
2Adjusted for sex, age, recruitment center and interventional group, smoking status (never smoker, former smoker and current smoker), baseline 2Adjusted for 
sex, age, recruitment center and interventional group, smoking status (never smoker, former smoker and current smoker), baseline body mass index, physical 
activity during leisure time, self-reported hypertension, self-reported depression, self-reported diabetes, self-reported hypercholesterolemia and education level 
(three categories) 
*p<0.05 ** p<0.001 
Western dietary pattern Q1 Q2 Q3 Q4  
n= 1804 n= 1804 n= 1804 n= 1804 p for trend 
Primary cardiovascular event (n) 67 61 65 84  
Person-years 7627 7590 7799 8024  
Men (%) 23.0 33.0 47.5 67.0 <0.001 
Age (y) 68.2±6.0 67.4±6.1 66.7±6.1 65.8±6.3 <0.001 
Multivariable model1 1 (ref) 0.95 (0.67-1.35) 0.94 (0.66-1.35) 1.00 (0.70-1.43) 0.93 
Multivariable model2 1 (ref) 0.96 (0.68-1.38) 0.97 (0.68-1.39) 1.05 (0.73-1.51) 0.73 
Mediterranean dietary  Q1 Q2 Q3 Q4  
Pattern n= 1804 n= 1804 n= 1804 n= 1804 p for trend 
Primary cardiovascular event (n) 104 70 54 49  
Person-years 7881 7599 7610 7950  
Men (%) 46.0 42.0 41.0 40.5 <0.001 
Age (y) 67.6±6.4 67.4±6.1 66.9±6.0 66.3±6.2 <0.001 
Multivariable model1 1(ref) 0.75 (0.55-1.02) 0.58 (0.41-0.81)** 0.50 (0.35-0.71)** <0.001 
Multivariable model2 1(ref) 0.76 (0.56-1.04) 0.60 (0.42-0.83)** 0.52 (0.36-0.74)** <0.001 
Table 5. Hazard Ratios for primary cardiovascular event according to quartiles of baseline adherence to the Western dietary pattern and 
Mediterranean dietary pattern in the PREDIMED study with the three intervention groups considered together (n= 7216) 
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in both multivariable models (P for trend <0.001), suggesting an inverse association between 198 
baseline adherence to the MDP and the risk of major cardiovascular events.  199 
To further analyze the association between empirically derived DP and cardiovascular events 200 
we repeated the analysis using each time as outcome each of the three components of the 201 
primary end-point of the trial, namely acute myocardial infarction, stroke and cardiovascular 202 
death (Table 6). For each of these analyses participants with the other 2 end-points were 203 
excluded. We observed that the MDP was inversely and strongly associated with the risk of 204 
myocardial infarction and also with the risk of cardiovascular death (fourth quartile vs first 205 
quartile: HR 0.52 ; 95% CI: 0.36, 0.74 and HR 0.37 ; 95%CI: 0.18, 0.76; respectively for each 206 
outcome in both adjusted models 2). Moreover, we found that higher baseline WDP 207 
adherence was significantly associated with a higher risk of cardiovascular death (p for linear 208 
trend = 0.033 in the multiple-adjusted model).209 
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Table 6. a) Hazard Ratios for acute myocardial infarction according to quartiles of baseline adherence to the Western dietary pattern and 
Mediterranean dietary pattern in the PREDIMED study with the three intervention groups considered together  
 
 
  
Western dietary pattern Q1 Q2 Q3 Q4  
    p for trend 
Acute Myocardial Infarction (n) 24 23 26 30  
Person-years 7508 7482 7662 7846  
Multivariable model1 1 (ref) 0.96 (0.54-1.72) 0.94 (0.52-1.68) 0.83 (0.46-1.50) 0.50 
Multivariable model2 1 (ref) 0.97 (0.54-1.74) 0.96 (0.53-1.72) 0.85 (0.47-1.56) 0.58 
      
Mediterranean dietary  Q1 Q2 Q3 Q4  
Pattern     p for trend 
Acute Myocardial Infarctation (n) 42 22 22 17  
Person-years 7675 7450 7517 7857  
Multivariable model1 1(ref) 0.57 (0.34-0.96)* 0.55 (0.32-0.93)* 0.38 (0.21-0.68)* 0.001 
Multivariable model2 1(ref) 0.59 (0.35-1.00) 0.58 (0.34-0.97)* 0.41 (0.23-0.75)* 0.003 
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b) Hazard Ratios for stroke according to quartiles of baseline adherence to the Western dietary pattern and Mediterranean dietary pattern in the 
PREDIMED study with the three intervention groups considered together 
 
 
 
 
 
Western dietary pattern Q1 Q2 Q3 Q4  
    p for trend 
Stroke (n) 37 33 31 34  
Person-years 7551 7520 7676 7856  
Multivariable model1 1 (ref) 0.99 (0.61-1.59) 0.91 (0.55-1.50) 0.94 (0.57-1.57) 0.78 
Multivariable model2 1 (ref) 1.03 (0.63-1.66) 0.98 (0.59-1.63) 1.05 (0.62-1.77) 0.89 
      
Mediterranean dietary  Q1 Q2 Q3 Q4  
Pattern     p for trend 
Stroke (n) 48 34 27 26  
Person-years 7688 7492 7526 7897  
Multivariable model1 1(ref) 0.81 (0.52-1.26) 0.67 (0.41-1.08) 0.66 (0.40-1.10) 0.073 
Multivariable model2 1(ref) 0.81 (0.52-1.26) 0.66 (0.41-1.08) 0.68 (0.41-1.13) 0.086 
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c) Hazard Ratios for cardiovascular death according to quartiles of baseline adherence to the Western dietary pattern and Mediterranean dietary 
pattern in the PREDIMED study with the three intervention groups considered together 
 
 
1Adjusted for sex, age, recruitment center and interventional group. 
2Adjusted for sex, age, recruitment center and interventional group, smoking status (never smoker, former smoker and current smoker), baseline 2Adjusted for 
sex, age, recruitment center and interventional group, smoking status (never smoker, former smoker and current smoker), baseline body mass index, physical 
activity during leisure time, self-reported hypertension, self-reported depression, self-reported diabetes, self-reported hypercholesterolemia and education level 
(three categories) 
*p<0.05 ** p<0.001 
Western dietary pattern Q1 Q2 Q3 Q4  
    p for trend 
Cardiovascular death (n) 14 14 20 33  
Person-years 7493 7467 7649 7872  
Multivariable model1 1 (ref) 1.03 (0.48-2.19) 1.41 (0.69-2.85) 1.90 (0.95-3.77) 0.031 
Multivariable model2 1 (ref) 1.03 (0.48-2.19) 1.37 (0.67-2.81) 1.91 (0.95-3.86) 0.033 
      
Mediterranean dietary  Q1 Q2 Q3 Q4  
Pattern     p for trend 
Cardiovascular death (n) 32 23 15 11  
Persons-years 7670 7472 7482 7857  
Multivariable model1 1(ref) 0.80 (0.47-1.38) 0.53 (0.28-0.99)* 0.36 (0.18-0.73)* 0.002 
Multivariable model2 1(ref) 0.84 (0.48-1.45) 0.56 (0.30-1.05) 0.37 (0.18-0.75)* 0.003 
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In order to assess the potential effect modification by the nutritional intervention we obtained 210 
the absolute risks of death or cardiovascular events for each of the 12 groups formed by the 211 
joint combination according to the nutritional intervention (3 levels) and the baseline 212 
adherence to DP (quartiles). We used inverse probability weighting in this analysis to avoid 213 
confounding and obtain exchangeable groups.  214 
Figure 1a displays the absolute overall risk of all-cause death (rate/1000 person-year) for 215 
each category made by the cross-classification according to quartiles of baseline adherence to 216 
the WDP and to the 3 randomized arms of the trial (the 2 intervention groups and the control 217 
group). Although statistically non-significant (p for trend=0.098), a suggestion for a trend of 218 
higher total mortality with higher quartiles of the WDP was present only in the control group, 219 
but not in the two active intervention groups. The highest absolute risk of death was observed 220 
in participants who were in the highest quartile of baseline adherence to the WDP and did not 221 
receive the intervention with MeDiet (i.e. they were allocated to the control group). 222 
Likewise, figure 1b shows that regardless of the intervention group, better baseline adherence 223 
to the MDP seemed to be associated with lower absolute risks for overall mortality in the 224 
three groups, being the inverse dose-response trend statistically significant in the control and 225 
in the PREDIMED active intervention group supplemented with EVOO (p for trend=0.012 226 
and 0.027 respectively).  227 
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Figure 2a shows the absolute all-cause mortality risk (rate/1000 person-year) for each 203 
category built according to the joint classification by quartiles of WDP and allocated 204 
intervention arm in the trial. No statistically significant interactions were found. 205 
Finally, figure 2b represents the cardiovascular risk according to the joint classification by 206 
both baseline adherence to the empirically-derived MDP and the allocated intervention arm. 207 
These absolute rates might suggest that, even in absence of the PREDIMED nutritional 208 
intervention (i.e., in the control group), the inverse association between baseline adherence to 209 
MDP and cardiovascular events was clearly apparent. Interestingly, the lowest absolute rates 210 
of cardiovascular events were observed in both intervention groups for the 2 upper quartiles 211 
of adherence to the baseline MDP (in the group supplemented with nuts) and for the fourth 212 
quartile (in the group supplemented with EVOO). The inverse dose-response trend between 213 
baseline adherence to the MDP and cardiovascular events remained significant within both 214 
intervention groups (p for trend=0.013 for EVOO and 0.007 for nuts).215 
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To deepen into the combined effects of baseline DP and intervention on overall mortality or 218 
cardiovascular events, we assessed the potential interactions between both factors. When the 219 
two intervention groups with MeDiet were merged together, we found a p-value=0.054 for the 220 
interaction between the highest quartile of WDP and the MeDiet intervention in the analysis 221 
of all-cause death. However, the likelihood ratio test assessing the overall effect modification 222 
was not statistically significant (3 degrees of freedom, p=0.27) 223 
DISCUSSION 224 
Using factor analysis, we investigated the association between baseline adherence to 225 
empirically-derived DP (i.e. post hoc patterns) and all-cause mortality or major cardiovascular 226 
events in a cohort of older Spanish subjects at high risk of CVD who underwent a nutritional 227 
intervention in the PREDIMED trial  [18, 19]. Two DP were identified: WDP and MDP (table 228 
1). The results showed that a closer baseline adherence to the MDP was associated with a 229 
statistically significant 47% reduction in all-cause mortality along the follow-up period. An 230 
inverse association of similar magnitude was also observed between the baseline adherence to 231 
the MDP and cardiovascular events. These inverse associations between baseline adherence to 232 
the MDP and overall mortality or cardiovascular events were always present, in a low or high 233 
magnitude, regardless of the allocated intervention group. However, the intervention with the 234 
MeDiet, supplemented with EVOO or nuts, in conjunction with a good baseline conformity 235 
with a MDP led to the lowest absolute cardiovascular risk. On the other hand, although no 236 
significant results were found, a (non-significant) suggestion for a detrimental association of 237 
the WDP with a higher risk of all-cause death was present in the control group.  Interestingly, 238 
when specific cardiovascular events were separately analyzed, an association of the WDP 239 
with a higher risk of cardiovascular death was found. Both findings suggest a detrimental 240 
effect of WDP leading to a higher mortality risk. 241 
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An interesting point of our study is that we were able to assess the combined effects on hard 242 
clinical end-points of both the baseline adherence to empirically-derived DP and of a dietary 243 
intervention. We observed that in the control group the differences between the highest and 244 
lowest quartiles of both the WDP and the MDP appeared to be more apparent, especially 245 
when mortality was analyzed. Control group subjects in the highest quartile of baseline 246 
adherence to MDP exhibited a 42% relative reduction in their mortality risk compared to their 247 
counterparts in the lowest quartile.  248 
The present findings assume that the baseline DP might be a good proxy for lifetime dietary 249 
exposures. In this line of thought, lifetime exposure can be more important to prevent 250 
premature mortality than to follow a supplemented MeDiet or a low-fat diet for only 4 to 5 251 
years. However, we were not able to demonstrate a potential interaction between a high 252 
baseline adherence to WDP and the intervention with MeDiet (both active intervention groups 253 
merged together versus control), though the p value approached the limit of statistical 254 
significance (p=0.054). 255 
Few studies have examined the association between a healthy DP using factor analysis and 256 
the risk of death in high-risk elderly populations [8, 19]. Our results agree with previous 257 
reports from the Mediterranean area [8] and non-Mediterranean countries [19], where a MDP 258 
was not always identified. In the same context, there are few studies analyzing empirically 259 
derived DP and CVD [8, 20], and they also found that in Mediterranean areas, better 260 
adherence to a MDP was associated with lower CVD risk.  261 
Our results are also consistent with previous studies that have reported inverse associations 262 
between an a priori defined MDP (or a DP similar to this traditional diet) and total mortality 263 
[19, 21, 22]. In relation to CVD, there are several studies analyzing the effects of a priori 264 
defined MDP, that found a cardio-protective effect of this DP [23, 24]. However, different 265 
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country-specific DP have been described in Mediterranean populations and these results 266 
should be interpreted with caution.  267 
Regarding the Spanish context, a recent study in a large cohort found that higher adherence to 268 
an empirically derived MDP in adults was associated with a reduction in the risk of all-cause 269 
mortality [6].Several explanations can account for the inverse association observed between 270 
better baseline adherence to a MDP and mortality. First, the MDP has been shown to have a 271 
beneficial effect on the incidence and prevalence of several diseases [25]. Second, plant-based 272 
foods are protective and plant-based DP may decrease disease risk, whereas diets high in 273 
animal foods may be more likely to increase the risk of mortality [26]. In fact, participants in 274 
the upper baseline quartiles of MDP followed a diet rich in plant based foods and poor in 275 
animal foods, and had the lowest risk of mortality. Third, the available evidence about olive 276 
oil, suggests that it plays a role in the prevention of coronary heart disease, and cancer, and 277 
may influence survival [1, 2, 21, 22, 25] . Besides, olive oil and particularly EVOO improves 278 
the lipid profile and has potent antioxidant and anti- inflammatory properties [27, 28] . 279 
Though we found a WDP associated with higher cardiovascular mortality, the absence of 280 
association between WDP and all-cause mortality was unexpected. Several mechanisms 281 
might also be proposed to explain this absence of association. A suggested explanation is that 282 
the “WDP” described in the U.S.[7]  and the “WDP” in our study are not entirely equivalent 283 
and may not produce the same potential adverse effects on health and longevity. Thus, the 284 
consumption of foods known to be associated with lower mortality, such as fish and seafood 285 
and alcohol in moderation [29], was included in the so-called WDP in our cohort. Besides, it 286 
is possible that residual confounding may have affected our results.  287 
 Our study has several strengths, including the opportunity to assess the combined effects of 288 
the baseline diet and the dietary intervention, the large sample size, the Mediterranean setting, 289 
the prolonged follow-up, the sub-studies conducted to validate the questionnaire [30], and the 290 
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objective, blinded and comprehensive ascertainment of events and close follow-up of 291 
participants.  292 
There are also limitations to our study. First, the results cannot be generalized to younger 293 
and/or healthier individuals from other geographical locations. Second, there is an inherent 294 
difficulty to change dietary habits in elderly subjects. Third, even though we adjusted the data 295 
for the main known risk factors for mortality or CVD, residual confounding cannot be 296 
completely excluded. Fourth, there is a potential for measurement error in the FFQ, which 297 
provides only subjective information in comparison with the use of objective markers of food 298 
intake. Fifth, the number of observed deaths was small. Despite this last limitation, which is 299 
associated with lower statistical power, we found a significant inverse association between the 300 
MDP and total mortality. Finally, the method used to define DP (factor analysis) involves 301 
several questionable decisions that must be taken into account (e.g. the definition and 302 
categorization of predefined food groups). Nevertheless, our results are in line with those of 303 
other studies using similar factor analyses to define DP.  304 
In conclusion, in a population of Spanish Mediterranean individuals at high cardiovascular 305 
risk participating in a nutritional intervention trial, a greater baseline adherence to a MDP was 306 
associated with a substantial reduction in CVD and overall mortality after follow-up for ≈5 y. 307 
Further research is required to confirm the present findings in other Mediterranean and non-308 
Mediterranean settings, especially to better observe if the MeDiet could be able to reduce the 309 
detrimental effect of a baseline WDP on cardiovascular or overall mortality risk.  310 
 311 
  312 
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Figure and table legends 
Table 1. Factor loadings for the two major dietary patterns in the PREDIMED study 
 
Table 2. Baseline characteristics of the 7216 participants according to quartiles of adherence 
to Western Dietary Pattern (WDP) 
Table 3. Baseline characteristics of the 7216 participants according to quartiles of adherence 
to Mediterranean Dietary Pattern (MDP) 
Table 4. Hazard ratios for total mortality according to quartiles of baseline adherence to the 
Western dietary pattern and Mediterranean dietary pattern in the PREDIMED study with the 
three intervention groups considered together (n= 7216) 
Table 5. Hazard Ratios for primary cardiovascular event according to quartiles of baseline 
adherence to the Western dietary pattern and Mediterranean dietary pattern in the 
PREDIMED study with the three intervention groups considered together (n= 7216) 
Table 6. a) Hazard Ratios for acute myocardial infarction according to quartiles of baseline 
adherence to the Western dietary pattern and Mediterranean dietary pattern in the 
PREDIMED study with the three intervention groups considered together. 
b) Hazard Ratios for stroke according to quartiles of baseline adherence to the Western 
dietary pattern and Mediterranean dietary pattern in the PREDIMED study with the three 
intervention groups considered together. 
c) Hazard Ratios for cardiovascular death according to quartiles of baseline adherence to the 
Western dietary pattern and Mediterranean dietary pattern in the PREDIMED study with the 
three intervention groups considered together. 
Figure 1. Absolute risks1 for overall mortality according to the quartiles of baseline 
adherence to WDP (a) or MDP (b) and to the randomly allocated arm of the trial (intervention 
groups or control group).  
                                                 
1 Absolute risks were adjusted for potential confounders using inverse probability weighting. 
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MDP:Mediterranean Dietary Pattern, WDP: Western Dietary Pattern. 
Figure 2. Absolute risks2 for cardiovascular events according to the quartiles of baseline 
adherence to WDP (a) or MDP (b) and and to the randomly allocated arm of the trial 
(intervention groups or control group).. 
MDP:Mediterranean Dietary Pattern, WDP: Western Dietary Pattern. 
 
  
                                                 
2 Absolute risks were adjusted for potential confounders using inverse probability weighting. 
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